학술논문

Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial
Document Type
Article
Source
In The Lancet Gastroenterology & Hepatology September 2023 8(9):803-815
Subject
Primary Research
Articles
Language
ISSN
2468-1253